Chorionic villus sampling and amniocentesis.

Area of Science:

• Medical Genetics
• Prenatal Diagnosis
• Obstetrics

Background:

• Invasive prenatal diagnostic methods like chorionic villus sampling (CVS) and amniocentesis are crucial for genetic investigations.
• Several aspects, including complication rates and optimal gestational ages, remain debated.
• New investigations provide updated insights into the safety and efficacy of these procedures.

Purpose of the Study:

• To review the advantages and disadvantages of common invasive prenatal diagnostic methods.
• To present current evidence on chorionic villus sampling and amniocentesis, focusing on recent findings.
• To clarify the optimal use of these techniques in genetic counseling.

Main Methods:

• Review of recent investigations and randomized trials comparing early amniocentesis and late chorionic villus sampling.
• Analysis of maternal and fetal complication data from mid-trimester amniocentesis.
• Evaluation of studies addressing potential teratogenic effects of chorionic villus sampling.

Main Results:

• Transabdominal chorionic villus sampling is confirmed as safer than early amniocentesis.
• Controversies persist regarding fetal loss rates and complications, particularly with extended gestational age use.
• Evidence suggests chorionic villus sampling may have distinct teratogenic effects, though this remains under investigation.

Conclusions:

• Transabdominal chorionic villus sampling is the gold standard for genetic investigations between 10-15 weeks gestation.
• It offers rapid diagnosis for aneuploidies detected in early screening.
• With experienced operators, it provides high efficiency and reliability comparable to amniocentesis but with fewer complications.